M. Treskes

1.2k total citations
26 papers, 988 citations indexed

About

M. Treskes is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, M. Treskes has authored 26 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in M. Treskes's work include Chemotherapy-induced organ toxicity mitigation (4 papers), Metal complexes synthesis and properties (3 papers) and Cancer therapeutics and mechanisms (3 papers). M. Treskes is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (4 papers), Metal complexes synthesis and properties (3 papers) and Cancer therapeutics and mechanisms (3 papers). M. Treskes collaborates with scholars based in Netherlands, Curacao and United Kingdom. M. Treskes's co-authors include W. J. F. van der Vijgh, Rob J. Bosman, Heleen M. Oudemans–van Straaten, D. F. Zandstra, Herbert M. Pinedo, Yvo M. Smulders, Leo Nijtmans, U. Holwerda, J. Silberbusch and Ed H. Slaats and has published in prestigious journals such as Diabetes Care, Arteriosclerosis Thrombosis and Vascular Biology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M. Treskes

26 papers receiving 949 citations

Peers

M. Treskes
Israeli A. Jaffe United States
R. J. Walton United Kingdom
S Arimori Japan
Jonathan R. Diamond United States
Yiyan Liu United States
Miho Hida Japan
Teut Risler Germany
Desmond Padhi United States
Israeli A. Jaffe United States
M. Treskes
Citations per year, relative to M. Treskes M. Treskes (= 1×) peers Israeli A. Jaffe

Countries citing papers authored by M. Treskes

Since Specialization
Citations

This map shows the geographic impact of M. Treskes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Treskes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Treskes more than expected).

Fields of papers citing papers by M. Treskes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Treskes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Treskes. The network helps show where M. Treskes may publish in the future.

Co-authorship network of co-authors of M. Treskes

This figure shows the co-authorship network connecting the top 25 collaborators of M. Treskes. A scholar is included among the top collaborators of M. Treskes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Treskes. M. Treskes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolk, J.H. van der, et al.. (2011). Diabetes mellitus in a 50-year-old captive Asian elephant (Elaphas maximus) bull. Veterinary Quarterly. 31(2). 99–101. 4 indexed citations
2.
Junge, Wolfgang, et al.. (2001). Multicenter evaluation of new liquid GGT and ALP reagents with new reference standardization and determination of reference intervals. 346. 4 indexed citations
3.
Straaten, Heleen M. Oudemans–van, et al.. (2000). Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Medicine. 27(1). 84–90. 238 indexed citations
4.
Smulders, Yvo M., et al.. (1999). Fasting and Post-Methionine Homocysteine Levels in NIDDM. 43 indexed citations
5.
Smulders, Yvo M., Ed H. Slaats, M. Treskes, et al.. (1999). Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.. Diabetes Care. 22(1). 125–132. 118 indexed citations
6.
Treskes, M., et al.. (1996). Multicentre evaluation of the EBIO plus glucose analyser.. PubMed. 34(9). 777–84. 6 indexed citations
7.
Treskes, M., et al.. (1996). Marked interference of hyperglycemia in measurements of mean (red) cell volume by Technicon H analyzers.. PubMed. 42(1). 76–80. 12 indexed citations
8.
Treskes, M., et al.. (1996). Marked interference of hyperglycemia in measurements of mean (red) cell volume by Technicon H analyzers. Clinical Chemistry. 42(1). 76–80. 9 indexed citations
9.
Treskes, M., Epie Boven, Arjan A. van de Loosdrecht, et al.. (1994). Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice. European Journal of Cancer. 30(2). 183–187. 55 indexed citations
10.
Treskes, M., Leo Nijtmans, Anne Marie J. Fichtinger-Schepman, & W. J. F. van der Vijgh. (1993). Cytostatic activity of cisplatin in the presence of WR2721 and its thiol metabolite WR1065 in OVCAR-3 human ovarian cancer cells as compared to V79 fibroblasts.. PubMed. 12(6B). 2261–5. 14 indexed citations
11.
Treskes, M. & W. J. F. van der Vijgh. (1993). WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach. Cancer Chemotherapy and Pharmacology. 33(2). 93–106. 99 indexed citations
12.
Mans, Dennis R.A., Gerrit Jan Schuurhuis, M. Treskes, et al.. (1992). Modulation by d,l-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines. European Journal of Cancer. 28(8-9). 1447–1452. 24 indexed citations
13.
Treskes, M., Leo Nijtmans, Anne Marie J. Fichtinger-Schepman, & W. J. F. van der Vijgh. (1992). Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate. Biochemical Pharmacology. 43(5). 1013–1019. 66 indexed citations
14.
Treskes, M., U. Holwerda, Leo Nijtmans, Herbert M. Pinedo, & W. J. F. van der Vijgh. (1992). The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278. Cancer Chemotherapy and Pharmacology. 29(6). 467–470. 25 indexed citations
15.
Treskes, M., Epie Boven, U. Holwerda, Herbert M. Pinedo, & W J van der Vijgh. (1992). Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse.. PubMed. 52(8). 2257–60. 61 indexed citations
16.
Laar, Jan van, et al.. (1992). Effect of WR-2721 on the toxicity and antitumor activity of the combination of carboplatin and 5-fluorouracil. Cancer Chemotherapy and Pharmacology. 31(2). 97–102. 27 indexed citations
17.
Peters, Godefridus J., C.L. van der Wilt, Jan van Laar, et al.. (1992). Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouracil. International Journal of Radiation Oncology*Biology*Physics. 22(4). 785–789. 20 indexed citations
18.
Treskes, M., et al.. (1991). The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin. Biochemical Pharmacology. 42(11). 2125–2130. 39 indexed citations
19.
Wilbrink, Maarten H., M. Treskes, T.A. de Vlieger, & Nico Vermeulen. (1990). Comparative toxicokinetics of 2,2′- and 4,4′-dichlorobiphenyls in the pond snailLymnaea stagnalis (L.). Archives of Environmental Contamination and Toxicology. 19(4). 565–571. 21 indexed citations
20.
Goewie, C.E., et al.. (1986). Determination of Pentachlorophenol in Wood Samples Using Liquid Chromatography With UV Absorbance, Amperometric and Electron-Capture Detection. International Journal of Environmental & Analytical Chemistry. 26(3-4). 305–318. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026